Differences in uptake of 14 nm PEG-liganded gold nanoparticles into BEAS-2B cells is dependent on their functional groups.


Journal

Toxicology and applied pharmacology
ISSN: 1096-0333
Titre abrégé: Toxicol Appl Pharmacol
Pays: United States
ID NLM: 0416575

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 21 09 2018
revised: 26 11 2018
accepted: 28 11 2018
pubmed: 12 12 2018
medline: 19 7 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Physico-chemical characteristics of nanoparticles have been shown to alter the uptake and toxicity of nanoparticles. This study investigated the uptake of six gold nanoparticles (AuNPs) into the human bronchial epithelial cell line BEAS-2B. The AuNPs studied included colloidal citrate-stabilised AuNPs of 14 nm in diameter; and 14 nm AuNPs conjugated to functional groups via polyethylene glycol (PEG), namely hydroxyl-PEG (POH), carboxyl-PEG (PCOOH), biotin-PEG (PBtn), nitrilotriacetic acid-PEG (PNTA), and azide-PEG (PAZ). Uptake was visualised by dark field microscopy using the CytoViva Hyperspectral Imaging system and after a 2 hour incubation at 37 °C, uptake was observed in cells treated with the citrate-stabilised and PCOOH AuNPs. However, no uptake was observed for the POH, PBtn, PNTA, or PAZ AuNPs, even after 24 h of incubation. An investigation into the energy dependence of uptake of the citrate-stabilised and PCOOH AuNPs showed that uptake was an active process. Cells pre-treated with either chlorpromazine or genistein as endocytosis inhibitors for clathrin- and caveolae-mediated pathways respectively, prior to addition of AuNPs, suggested a caveolae-dependent mechanism of endocytosis. These results further support recent findings on the mechanism of intracellular uptake and localisation and the subsequent toxicity of nanoparticles.

Identifiants

pubmed: 30529166
pii: S0041-008X(18)30534-9
doi: 10.1016/j.taap.2018.11.014
pii:
doi:

Substances chimiques

Colloids 0
Citric Acid 2968PHW8QP
Polyethylene Glycols 3WJQ0SDW1A
Gold 7440-57-5
Genistein DH2M523P0H
Chlorpromazine U42B7VYA4P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-141

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Melissa Vetten (M)

Toxicology Section, National Institute for Occupational Health, Johannesburg, South Africa; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: melissav@nioh.ac.za.

Mary Gulumian (M)

Toxicology Section, National Institute for Occupational Health, Johannesburg, South Africa; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: mary.gulumian@nioh.nhls.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH